Hemodialysis-based interventions to preserve cognitive function

以血液透析为基础的干预措施以保留认知功能

基本信息

项目摘要

ABSTRACT Over 640,000 US adults suffer from ESRD, >95% of whom receive hemodialysis (HD) for the rest of their life or until transplantation. Kidney disease and HD significantly impact cognitive function, especially higher-order executive function. Only 13% of HD patients have normal cognition; HD patients experience executive function impairment at a rate 3-fold higher than the general population, leading to hospitalization, disability, and death. Studies of older adults suggest that the only effective interventions for preserving executive function are cognitive training (CT) and/or exercise training (ET). These modalities have not been tested for executive function preservation in HD patients; even younger HD patients suffer substantial executive function impairment and could benefit from these interventions. HD frequency (3 sessions a week) and duration (4-6 hours/session) makes HD patients a “captive audience” for intradialytic CT and/or ET to mitigate executive function decline. In preliminary studies, HD patients reported spending most of their time watching TV; intradialytic CT and/or ET could replace these passive activities. In preliminary studies, 87% of nephrology providers believed that their patients would be interested in intradialytic CT and 83% believed that their patients would be interested in intradialytic ET. Among HD patients, 67% wanted to improve their cognition through CT and 71% wanted to improve their strength and cognition through ET while undergoing HD. To test the feasibility of intradialytic interventions, we conducted a pilot RCT of 20 HD patients, comparing standard of care to CT or ET; even in this pilot, we found that intradialytic CT and ET preserved executive function. As expected, executive function in patients receiving standard of care declined substantially by 3 months (difference=47.4 seconds, P=0.006); however, this decline was not seen among those receiving CT or ET. Compared with standard of care, the difference in mean change was -46.72 seconds (95% CI: -91.12, - 2.31; P=0.04) for CT and -56.21 seconds (95% CI: -105.86, -6.56; P=0.03) for ET. In just 3 months, CT and ET preserved executive function compared to a striking decline with standard of care. To properly test the impact of intradialytic CT and/or ET, on the executive function decline associated with HD, we propose the following aims: 1) To conduct an RCT to evaluate executive function decline in the setting of intradialytic CT and/or ET, 2) To quantify the effects of intradialytic CT and/or ET on ESRD-specific clinical outcomes, 3) To quantify the effects of intradialytic CT and/or ET, on patient-centered outcomes. Through this RCT, we will learn the impact of two potential non-pharmacological interventions, cognitive and exercise training, in preserving executive function during HD. If successful, this will improve HD outcomes of >640,000 adults with ESRD. For the first time, we will have validated, beneficial activities replace the typical passive activities of HD patients. Our findings will be implementable in dialysis centers across the country to help reduce the decline in executive function.
ABSTRACT Over 640,000 US adults suffer from ESRD, >95% of whom receive hemodialysis (HD) for the rest of their life or until transplantation. Kidney disease and HD significantly impact cognitive function, especially higher-order executive function. Only 13% of HD patients have normal cognition; HD patients experience executive function impairment at a rate 3-fold higher than the general population, leading to hospitalization, disability, and death. Studies of older adults suggest that the only effective interventions for preserving executive function are cognitive training (CT) and/or exercise training (ET). These modalities have not been tested for executive function preservation in HD patients; even younger HD patients suffer substantial executive function impairment and could benefit from these interventions. HD frequency (3 sessions a week) and duration (4-6 hours/session) makes HD patients a “captive audience” for intradialytic CT and/or ET to mitigate executive function decline. In preliminary studies, HD patients reported spending most of their time watching TV; intradialytic CT and/or ET could replace these passive activities. In preliminary studies, 87% of nephrology providers believed that their patients would be interested in intradialytic CT and 83% believed that their patients would be interested in intradialytic ET. Among HD patients, 67% wanted to improve their cognition through CT and 71% wanted to improve their strength and cognition through ET while undergoing HD. To test the feasibility of intradialytic interventions, we conducted a pilot RCT of 20 HD patients, comparing standard of care to CT or ET; even in this pilot, we found that intradialytic CT and ET preserved executive function. As expected, executive function in patients receiving standard of care declined substantially by 3 months (difference=47.4 seconds, P=0.006); however, this decline was not seen among those receiving CT or ET. Compared with standard of care, the difference in mean change was -46.72 seconds (95% CI: -91.12, - 2.31; P=0.04) for CT and -56.21 seconds (95% CI: -105.86, -6.56; P=0.03) for ET. In just 3 months, CT and ET preserved executive function compared to a striking decline with standard of care. To properly test the impact of intradialytic CT and/or ET, on the executive function decline associated with HD, we propose the following aims: 1) To conduct an RCT to evaluate executive function decline in the setting of intradialytic CT and/or ET, 2) To quantify the effects of intradialytic CT and/or ET on ESRD-specific clinical outcomes, 3) To quantify the effects of intradialytic CT and/or ET, on patient-centered outcomes. Through this RCT, we will learn the impact of two potential non-pharmacological interventions, cognitive and exercise training, in preserving executive function during HD. If successful, this will improve HD outcomes of >640,000 adults with ESRD. For the first time, we will have validated, beneficial activities replace the typical passive activities of HD patients. Our findings will be implementable in dialysis centers across the country to help reduce the decline in executive function.

项目成果

期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Racial differences in inflammation and outcomes of aging among kidney transplant candidates.
肾移植候选者之间炎症和衰老结果的种族差异。
  • DOI:
    10.1186/s12882-019-1360-8
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    Shrestha,Prakriti;Haugen,ChristineE;Chu,NadiaM;Shaffer,Ashton;Garonzik-Wang,Jacqueline;Norman,SilasP;Walston,JeremyD;Segev,DorryL;McAdams-DeMarco,MaraA
  • 通讯作者:
    McAdams-DeMarco,MaraA
Kidney transplant outcomes in recipients with visual, hearing, physical and walking impairments: a prospective cohort study.
视力、听力、身体和行走障碍受者的肾移植结果:一项前瞻性队列研究。
Intradialytic Activities and Health-Related Quality of Life Among Hemodialysis Patients.
血液透析患者的透析中活动和健康相关的生活质量。
  • DOI:
    10.1159/000492623
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Warsame,Fatima;Ying,Hao;Haugen,ChristineE;Thomas,AlvinG;Crews,DeidraC;Shafi,Tariq;Jaar,Bernard;Chu,NadiaM;Segev,DorryL;McAdams-DeMarco,MaraA
  • 通讯作者:
    McAdams-DeMarco,MaraA
Interventions Made to Preserve Cognitive Function Trial (IMPCT) study protocol: a multi-dialysis center 2x2 factorial randomized controlled trial of intradialytic cognitive and exercise training to preserve cognitive function.
维持认知功能干预试验 (IMPCT) 研究方案:一项多透析中心 2x2 析因随机对照试验,涉及透析中认知和运动训练以维持认知功能。
  • DOI:
    10.1186/s12882-020-02041-y
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    McAdams-DeMarco,MaraA;Chu,NadiaM;Steckel,Malu;Kunwar,Sneha;GonzálezFernández,Marlís;Carlson,MichelleC;Fine,DerekM;Appel,LawrenceJ;Diener-West,Marie;Segev,DorryL
  • 通讯作者:
    Segev,DorryL
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mara A. McAdams DeMarco其他文献

Recipient Age and Time Spent Hospitalized in the Year Before and After Kidney Transplantation
肾移植前后一年受者年龄和住院时间
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    M. Grams;Mara A. McAdams DeMarco;L. Kucirka;D. Segev
  • 通讯作者:
    D. Segev
Abdominal CT measurements of body composition and waitlist mortality in kidney transplant candidates.
腹部 CT 测量肾移植候选者的身体成分和候补死亡率。
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Evelien E. Quint;Yi Liu;O. Shafaat;Nidhi Ghildayal;Helen Crosby;A. Kamireddy;Robert A. Pol;B. Orandi;Dorry L. Segev;Clifford R. Weiss;Mara A. McAdams DeMarco
  • 通讯作者:
    Mara A. McAdams DeMarco

Mara A. McAdams DeMarco的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mara A. McAdams DeMarco', 18)}}的其他基金

Cognitive prehabilitation to prevent Alzheimer's disease after kidney transplantation
认知预康复预防肾移植后阿尔茨海默病
  • 批准号:
    10557957
  • 财政年份:
    2022
  • 资助金额:
    $ 54.18万
  • 项目类别:
Impact of climate change on cognitive and physical aging of older kidney transplant recipients
气候变化对老年肾移植受者认知和身体衰老的影响
  • 批准号:
    10838643
  • 财政年份:
    2022
  • 资助金额:
    $ 54.18万
  • 项目类别:
Structural Racism, Resilience, and Premature Cognitive Aging in End-stage Renal Disease
终末期肾病中的结构性种族主义、复原力和过早认知衰老
  • 批准号:
    10471530
  • 财政年份:
    2022
  • 资助金额:
    $ 54.18万
  • 项目类别:
Structural Racism, Resilience, and Premature Cognitive Aging in End-stage Renal Disease
终末期肾病中的结构性种族主义、复原力和过早认知衰老
  • 批准号:
    10659198
  • 财政年份:
    2022
  • 资助金额:
    $ 54.18万
  • 项目类别:
Hemodialysis-based interventions to preserve cognitive function
以血液透析为基础的干预措施以保留认知功能
  • 批准号:
    10320432
  • 财政年份:
    2018
  • 资助金额:
    $ 54.18万
  • 项目类别:
Developing personalized immunosuppression for older kidney transplant recipients
为老年肾移植受者开发个性化免疫抑制
  • 批准号:
    10598964
  • 财政年份:
    2018
  • 资助金额:
    $ 54.18万
  • 项目类别:
Alzheimer's Supplement to Hemodialysis-based interventions to preserve cognitive function
阿尔茨海默病补充血液透析干预措施以保持认知功能
  • 批准号:
    10286431
  • 财政年份:
    2018
  • 资助金额:
    $ 54.18万
  • 项目类别:
Developing personalized immunosuppression for older kidney transplant recipients
为老年肾移植受者开发个性化免疫抑制
  • 批准号:
    10304934
  • 财政年份:
    2018
  • 资助金额:
    $ 54.18万
  • 项目类别:
Developing personalized immunosuppression for older kidney transplant recipients
为老年肾移植受者开发个性化免疫抑制
  • 批准号:
    10063523
  • 财政年份:
    2018
  • 资助金额:
    $ 54.18万
  • 项目类别:
Alzheimer's Supplement to ESRD-specific physiologic age
阿尔茨海默病对 ESRD 特定生理年龄的补充
  • 批准号:
    10286420
  • 财政年份:
    2017
  • 资助金额:
    $ 54.18万
  • 项目类别:

相似海外基金

Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Fellowship
Clinitouch-360: A digital health platform enabling robust end-to-end care of patients in Primary Care with depression and anxiety
Clinitouch-360:数字健康平台,可为初级保健中的抑郁和焦虑患者提供强大的端到端护理
  • 批准号:
    10098274
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Collaborative R&D
Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
  • 批准号:
    10826673
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
Visual analysis system to detect and predict the signs of anxiety in healthcare
用于检测和预测医疗保健中焦虑迹象的视觉分析系统
  • 批准号:
    2902083
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Studentship
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Launchpad
Healthy Young Minds: co-producing a nature-based intervention with rural High School students to promote mental well-being and reduce anxiety
健康的年轻心灵:与农村高中生共同开展基于自然的干预措施,以促进心理健康并减少焦虑
  • 批准号:
    MR/Z503599/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Research Grant
"Flashforward" imagery and anxiety in young adults: Risk mechanisms and intervention development
年轻人的“闪现”意象和焦虑:风险机制和干预措施的发展
  • 批准号:
    MR/Y009460/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Fellowship
How parents manage climate anxiety: coping and hoping for the whole family
父母如何应对气候焦虑:全家人的应对和希望
  • 批准号:
    DP230101928
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Discovery Projects
An innovative biofeedback enhanced adaptive extended reality (XR) device to reduce perinatal pain and anxiety during and after childbirth
一种创新的生物反馈增强型自适应扩展现实 (XR) 设备,可减少分娩期间和分娩后的围产期疼痛和焦虑
  • 批准号:
    10097862
  • 财政年份:
    2024
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Collaborative R&D
Digital cognitive-behavior therapy for anxiety and depressive disorders: Building an impactful research project from international partnerships and knowledge exchange in primary care
针对焦虑和抑郁症的数字认知行为疗法:通过初级保健领域的国际合作和知识交流建立一个有影响力的研究项目
  • 批准号:
    480808
  • 财政年份:
    2023
  • 资助金额:
    $ 54.18万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了